FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068660068> ?p ?o ?g. }

• W2068660068 endingPage "132" @default.
• W2068660068 startingPage "126" @default.
• W2068660068 abstract "Amyloid beta (Abeta) may play a central role in the pathogenesis of Alzheimer disease. A functional gamma-secretase inhibitor, LY450139, was developed that inhibits Abeta formation in whole cell assays, transgenic mice, and beagle dogs. The authors wished to determine the safety and tolerability of this drug, and the reduction of Abeta in plasma and cerebrospinal fluid (CSF) after multiple doses. Volunteer subjects (N = 37) were studied using doses from 5 to 50 mg/day given for 14 days. Plasma and CSF concentrations of LY450139, Abeta(1-40) and Abeta(1-X) (Abeta(total)) were determined, and safety and tolerability were assessed. The plasma half-life of LY450139 was approximately 2.5 hours. Pharmacokinetic analyses showed a linear relationship between dose and plasma concentrations, with a Cmax of 828 +/- 19.2 ng/mL after a 50-mg dose. Plasma Abeta concentrations decreased in a dose-dependent manner over a 6-hour interval following drug administration, with a maximum decrease of approximately 40% relative to baseline. After returning to baseline, Abeta concentrations were transiently increased. CSF Abeta concentrations were unchanged. Adverse events reported by subjects taking 5-mg, 20-mg, or 40-mg doses were similar to those reported by subjects taking placebo. Two of 7 subjects taking 50 mg/day experienced adverse events that may have been drug related. In this phase 1 volunteer study, reported adverse events after taking LY450139 were manageable. A dose-dependent reduction in plasma Abeta was demonstrated, and changes in plasma Abeta concentrations were temporally related to the pharmacokinetic characteristics of LY450139." @default.
• W2068660068 created "2016-06-24" @default.
• W2068660068 creator A5020598459 @default.
• W2068660068 creator A5024139343 @default.
• W2068660068 creator A5024481033 @default.
• W2068660068 creator A5037725543 @default.
• W2068660068 creator A5046369974 @default.
• W2068660068 creator A5065575182 @default.
• W2068660068 creator A5071364728 @default.
• W2068660068 creator A5080609944 @default.
• W2068660068 date "2005-05-01" @default.
• W2068660068 modified "2023-09-26" @default.
• W2068660068 title "Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers" @default.
• W2068660068 cites W1524261859 @default.
• W2068660068 cites W1574188788 @default.
• W2068660068 cites W1675105744 @default.
• W2068660068 cites W1963669299 @default.
• W2068660068 cites W1967549235 @default.
• W2068660068 cites W1971834278 @default.
• W2068660068 cites W1978106990 @default.
• W2068660068 cites W1983577412 @default.
• W2068660068 cites W1984185140 @default.
• W2068660068 cites W1984769949 @default.
• W2068660068 cites W1993428183 @default.
• W2068660068 cites W1995650022 @default.
• W2068660068 cites W1997822484 @default.
• W2068660068 cites W1999631936 @default.
• W2068660068 cites W2002093986 @default.
• W2068660068 cites W2003076948 @default.
• W2068660068 cites W2004324219 @default.
• W2068660068 cites W2017779103 @default.
• W2068660068 cites W2023121717 @default.
• W2068660068 cites W2024121049 @default.
• W2068660068 cites W2026760314 @default.
• W2068660068 cites W2036362108 @default.
• W2068660068 cites W2048506492 @default.
• W2068660068 cites W2065184319 @default.
• W2068660068 cites W2067152403 @default.
• W2068660068 cites W2074098808 @default.
• W2068660068 cites W2084259920 @default.
• W2068660068 cites W2085706266 @default.
• W2068660068 cites W2090271811 @default.
• W2068660068 cites W2092356280 @default.
• W2068660068 cites W2097705657 @default.
• W2068660068 cites W2101077392 @default.
• W2068660068 cites W2103496509 @default.
• W2068660068 cites W2126800086 @default.
• W2068660068 cites W2132806643 @default.
• W2068660068 cites W2136680662 @default.
• W2068660068 cites W2146624464 @default.
• W2068660068 cites W2158509547 @default.
• W2068660068 cites W2162059739 @default.
• W2068660068 cites W2291294329 @default.
• W2068660068 doi "https://doi.org/10.1097/01.wnf.0000167360.27670.29" @default.
• W2068660068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15965311" @default.
• W2068660068 hasPublicationYear "2005" @default.
• W2068660068 type Work @default.
• W2068660068 sameAs 2068660068 @default.
• W2068660068 citedByCount "216" @default.
• W2068660068 countsByYear W20686600682012 @default.
• W2068660068 countsByYear W20686600682013 @default.
• W2068660068 countsByYear W20686600682014 @default.
• W2068660068 countsByYear W20686600682015 @default.
• W2068660068 countsByYear W20686600682016 @default.
• W2068660068 countsByYear W20686600682017 @default.
• W2068660068 countsByYear W20686600682018 @default.
• W2068660068 countsByYear W20686600682019 @default.
• W2068660068 countsByYear W20686600682020 @default.
• W2068660068 countsByYear W20686600682021 @default.
• W2068660068 countsByYear W20686600682022 @default.
• W2068660068 crossrefType "journal-article" @default.
• W2068660068 hasAuthorship W2068660068A5020598459 @default.
• W2068660068 hasAuthorship W2068660068A5024139343 @default.
• W2068660068 hasAuthorship W2068660068A5024481033 @default.
• W2068660068 hasAuthorship W2068660068A5037725543 @default.
• W2068660068 hasAuthorship W2068660068A5046369974 @default.
• W2068660068 hasAuthorship W2068660068A5065575182 @default.
• W2068660068 hasAuthorship W2068660068A5071364728 @default.
• W2068660068 hasAuthorship W2068660068A5080609944 @default.
• W2068660068 hasConcept C112705442 @default.
• W2068660068 hasConcept C126322002 @default.
• W2068660068 hasConcept C134018914 @default.
• W2068660068 hasConcept C142724271 @default.
• W2068660068 hasConcept C197934379 @default.
• W2068660068 hasConcept C204787440 @default.
• W2068660068 hasConcept C22979827 @default.
• W2068660068 hasConcept C27081682 @default.
• W2068660068 hasConcept C2776768635 @default.
• W2068660068 hasConcept C2776820430 @default.
• W2068660068 hasConcept C2778375690 @default.
• W2068660068 hasConcept C6557445 @default.
• W2068660068 hasConcept C71924100 @default.
• W2068660068 hasConcept C86803240 @default.
• W2068660068 hasConcept C98274493 @default.
• W2068660068 hasConceptScore W2068660068C112705442 @default.
• W2068660068 hasConceptScore W2068660068C126322002 @default.
• W2068660068 hasConceptScore W2068660068C134018914 @default.
• W2068660068 hasConceptScore W2068660068C142724271 @default.

• next